A Phase Ib Pilot Study of Itacitinib Combined with Alemtuzumab in Patients with T-Cell Prolymphocytic Leukemia (T-PLL) von Kadia, Tapan M., Ravandi, Farhad, Borthakur, Gautam, Yilmaz, Musa, Montalban-Bravo, Guillermo, Adewale, Lade, Pierce, Sherry A., Jain, Nitin, Ferrajoli, Alessandra, Wierda, William G., Kantarjian, Hagop

Volltext

A Phase II Study of CPX-351 Plus Venetoclax in Patients with Relapsed/Refractory (R/R) or Newly Diagnosed Acute Myeloid Leukemia (AML) von Kim, Kunhwa, Kantarjian, Hagop, Borthakur, Gautam, Takahashi, Koichi, Short, Nicholas J., DiNardo, Courtney D., Jabbour, Elias J., Chien, Kelly S., Daver, Naval, Pemmaraju, Naveen, Jain, Nitin, Adewale, Lade, Montalban-Bravo, Guillermo, Wierda, William G., Verstovsek, Srdan, Konopleva, Marina, Ravandi, Farhad, Kadia, Tapan M.

Volltext

Phase II Study of CPX-351 Plus Venetoclax in Patients with Acute Myeloid Leukemia (AML) von Kadia, Tapan M., Borthakur, Gautam, Takahashi, Koichi, DiNardo, Courtney D., Daver, Naval, Pemmaraju, Naveen, Jabbour, Elias, Jain, Nitin, Short, Nicholas J., Qiao, Wei, Adewale, Lade, Rausch, Caitlin R., Pierce, Sherry A., Alvarado, Yesid, Alousi, Amin M., Popat, Uday R., Khouri, Issa F., Garcia-Manero, Guillermo, Konopleva, Marina, Cortes, Jorge E., Ravandi, Farhad, Kantarjian, Hagop M.

Volltext